Related Experiment Video
Updated: Aug 15, 2026

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
Published on: March 2, 2011
Interleukin-6-type cytokines in vivo: regulated bioavailability
1Department of Cell Biology & Anatomy, New York Medical College, Valhalla, New York 10514, USA.
Insights
Interleukin-6 (IL-6) exists in circulation not freely, but as complexes with binding proteins. These "chaperoned" IL-6 complexes exhibit varying biological activity, suggesting a new regulatory mechanism for cytokine function.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Cytokines, such as interleukin-6 (IL-6), were traditionally considered free in circulation.
- IL-6 is known to bind with various proteins, forming complexes of different molecular masses.
Purpose of the Study:
- To investigate the complexed forms of IL-6 in human circulation.
- To understand the implications of these IL-6 complexes on cytokine bioavailability and function.
Main Methods:
- Analysis of circulating IL-6 complexes in human blood samples.
- Characterization of IL-6 complexes using biochemical and immunological assays.
- Assessment of ex vivo biological activity of different IL-6 complex forms.
Main Results:
- Circulating IL-6 was found in complexes with molecular masses of 400-500, 150-200, and 25-35 kDa.
- These complexes involve binding proteins including soluble IL-6 receptor (sIL-6R) and IgG antibodies.
- Elevated levels of specific IL-6 complexes were observed in cancer patients undergoing immunotherapy.
- The "chaperoned" IL-6 complexes demonstrated differential immunoreactivity and ex vivo biological activity.
Conclusions:
- Circulating IL-6 exists predominantly in a "chaperoned" state, bound within protein complexes.
- The formation of these IL-6 complexes represents a novel mechanism for regulating cytokine bioavailability and function in vivo.
- This finding has implications for understanding cytokine activity in inflammatory diseases and cancer immunotherapy.
Abstract:
Investigators have traditionally thought of the class of inflammation- and injury-associated cytokines in large part as "free" entities in the peripheral circulation. In the case of interleukin-6 (IL-6), the cytokine can be found in blood in complexes of molecular mass 400-500, 150-200, and 25-35 kDa in association with binding proteins that can include soluble IL-6 receptor (sIL-6R), anti-IL-6, and anti-sIL-6R IgG, and others. Sustained high levels of different particular IL-6 complexes are observed in the human circulation in cancer patients subjected to particular active anticancer immunotherapy regimens. In the "chaperoned" state, circulating IL-6 complexes display differential immunoreactivity in different ELISAs and possess differential biological activity as assayed ex vivo. The discovery of "chaperoned" circulating IL-6 in humans points to a new level of modulation of cytokine function, that of regulated bioavailability of IL-6 in vivo.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The JAK-STAT Signaling Pathway
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

